U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06795165) titled 'STUDY of the SAFETY and EFFICACY of MOXIDECTIN TABLETS for the REDUCTION of DEMODEX EYELASH INFESTATION' on Jan. 22.
Brief Summary: A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation
Study Start Date: Feb. 15
Study Type: INTERVENTIONAL
Condition:
Blepharitis
Intervention:
DRUG: Moxidectin 2 MG Oral Tablet
active medication
DRUG: Placebo
placebo pills
Recruitment Status: RECRUITING
Sponsor: Eye Research Foundation, Inc.
Published by HT Digital Content Services with permission fr...